Honokiol Inhibits Colorectal Cancer Cell Growth: Involvement of Hsp27 as a Molecular Target

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Honokiol (HK), a natural phenolic compound, demonstrates potent anti-cancer properties.
• Colorectal cancer (CRC) remains a significant global health challenge.
• Heat shock protein 27 (Hsp27) is implicated in cancer cell survival and drug resistance.

Purpose of the Study:

• To investigate the anti-cancer effects of Honokiol (HK) in colorectal cancer (CRC) cells.
• To identify heat shock protein 27 (Hsp27) as a direct molecular target of HK.
• To elucidate the mechanisms underlying HK's anti-cancer activity in CRC.

Main Methods:

• Honokiol (HK) isolation and purification.
• Cell viability, apoptosis, and cell cycle analysis via MTS assay and flow cytometry.
• Validation of HK-Hsp27 interaction using pull-down assays, molecular docking, and site-directed mutagenesis.
• Hsp27 knockdown using lentiviral shRNA and assessment of protein expression via Western blotting.

Main Results:

• HK dose-dependently suppressed anchorage-independent growth and induced G0/G1 cell cycle arrest in CRC cells.
• HK triggered apoptosis through modulation of apoptotic proteins and direct binding to Hsp27's α-crystallin domain.
• Hsp27 knockdown significantly reduced CRC cell growth, and HK treatment decreased Hsp27 protein levels.

Conclusions:

• Honokiol (HK) exhibits anti-cancer effects in colorectal cancer (CRC) by inhibiting Hsp27.
• The direct interaction between HK and Hsp27 suppresses tumor cell growth and promotes apoptosis.
• HK shows potential as a natural therapeutic agent for colorectal cancer (CRC).